Why is Boston Bio falling/rising?

As of 19-Sep, Boston Bio Systems Ltd's stock price is currently at 7.82, reflecting a decline of 0.53, or 6.35%. The stock has underperformed its sector by 4.16% today, and while it is higher than the 50-day and 100-day moving averages, it is lower than the 5-day, 20-day, and 200-day moving averages. Over the past week, the stock has decreased by 0.38%, and over the last month, it has fallen by 3.34%. There is a notable increase in investor participation, with delivery volume rising by 59.08% against the 5-day average, indicating some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the Sensex has shown a positive return of 0.88% over the past week and 1.20% over the past month, contrasting with Boston Bio's declines during the same periods. The medical equipment sector, in which Boston Bio operates, has also experienced a downturn of 2.05%. This broader market performance suggests that the stock's decline is not isolated but rather part of a larger trend affecting the sector, contributing to the stock's underperformance relative to the benchmark.